Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Pseudomonas aeruginosa is an antibiotic-refractory pathogen with a large genome and extensive genotypic diversity. Historically, P. aeruginosa has been a major model system for understanding the molecular mechanisms underlying type I clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated protein (CRISPR-Cas)-based bacterial immune system function. However, little information on the phylogenetic distribution and potential role of these CRISPR-Cas systems in molding the P. aeruginosa accessory genome and antibiotic resistance elements is known. Computational approaches were used to identify and characterize CRISPR-Cas systems within 672 genomes, and in the process, we identified a previously unreported and putatively mobile type I-C P. aeruginosa CRISPR-Cas system. Furthermore, genomes harboring noninhibited type I-F and I-E CRISPR-Cas systems were on average ~300 kb smaller than those without a CRISPR-Cas system. In silico analysis demonstrated that the accessory genome ( n = 22,036 genes) harbored the majority of identified CRISPR-Cas targets. We also assembled a global spacer library that aided the identification of difficult-to-characterize mobile genetic elements within next-generation sequencing (NGS) data and allowed CRISPR typing of a majority of P. aeruginosa strains. In summary, our analysis demonstrated that CRISPR-Cas systems play an important role in shaping the accessory genomes of globally distributed P. aeruginosa isolates. IMPORTANCE P. aeruginosa is both an antibiotic-refractory pathogen and an important model system for type I CRISPR-Cas bacterial immune systems. By combining the genome sequences of 672 newly and previously sequenced genomes, we were able to provide a global view of the phylogenetic distribution, conservation, and potential targets of these systems. This analysis identified a new and putatively mobile P. aeruginosa CRISPR-Cas subtype, characterized the diverse distribution of known CRISPR-inhibiting genes, and provided a potential new use for CRISPR spacer libraries in accessory genome analysis. Our data demonstrated the importance of CRISPR-Cas systems in modulating the accessory genomes of globally distributed strains while also providing substantial data for subsequent genomic and experimental studies in multiple fields. Understanding why certain genotypes of P. aeruginosa are clinically prevalent and adept at horizontally acquiring virulence and antibiotic resistance elements is of major clinical and economic importance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449 · cited 5×
“These data demonstrate that at least 41% of the clinical strains analyzed are at minimum MDRPA according to the breakpoints established by the Clinical and Lab- oratory Standards Institute (CLSI) (36).”
BackgroundMethodInfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“CRISPR-Cas bacterial immune modules protect bacteria and archaea from mobile genetic elements, such as plasmids and bacteriophages (phages) (18, 19).”
BackgroundComplete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573 · cited 1×
“Pseudomonas aeruginosa is a ubiquitous organism that colonizes a wide variety of surfaces and aquatic environments (1).”
BackgroundCRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Self-citationSmall CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460 · cited 1×
“Type I CRISPR arrays are transcribed as one large transcript that is processed within an identical repeat sequence into mature, small CRISPR RNAs (crRNAs) by a subtype-specific Cas6 protein (20, 21).”
BackgroundEvolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331 · cited 19×
“Utilizing our diverse data set, we identified strong correlations between resistance to multiple antibiotics and the absence of type I-F and I-E CRISPR-Cas systems; however, these correlations largely disappeared when the prevalent and largely CRISPR-Cas-deficient MDRPA STs 111 and 235 were removed.”
BackgroundInfluentialLister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789 · cited 2×
“human pathogen (3), and a common target for phage therapy”
BackgroundCRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA
Marraffini, L. A., & Sontheimer, E. J. (2008) · Science · doi:10.1126/science.1165771 · Cited by 1,642 · cited 2×
“CRISPR-Cas bacterial immune modules protect bacteria and archaea from mobile genetic elements, such as plasmids and bacteriophages (phages) (18, 19).”
BackgroundPourcel, C., Salvignol, G., & Vergnaud, G. (2005) · Microbiology · doi:10.1099/mic.0.27437-0 · Cited by 1,201
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Antibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolution
Botelho, J., Grosso, F., & Peixe, L. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.07.002 · Cited by 550
Innovative and rapid antimicrobial susceptibility testing systems
van Belkum, A., Burnham, C.-A. D., Rossen, J. W. A., Mallard, F., Rochas, O., & Dunne, W. M. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0327-x · Cited by 355
Self-citationCook, R., Brown, N., Redgwell, T., Rihtman, B., Barnes, M., Clokie, M., Stekel, D. J., Hobman, J., Jones, M. A., & Millard, A. (2021) · PHAGE · doi:10.1089/phage.2021.0007 · Cited by 334
Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species
Pawluk, A., Staals, R. H. J., Taylor, C., Watson, B. N. J., Saha, S., Fineran, P. C., Maxwell, K. L., & Davidson, A. R. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.85 · Cited by 311
Mukama, O., Wu, J., Li, Z., Liang, Q., Yi, Z., Lu, X., Liu, Y., Liu, Y., Hussain, M., Makafe, G. G., et al. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112143 · Cited by 288
Discovery of widespread type I and type V CRISPR-Cas inhibitors
Marino, N. D., Zhang, J. Y., Borges, A. L., Sousa, A. A., Leon, L. M., Rauch, B. J., Walton, R. T., Berry, J. D., Joung, J. K., Kleinstiver, B. P., et al. (2018) · Science · doi:10.1126/science.aau5174 · Cited by 279
Evolutionary Ecology of Prokaryotic Immune Mechanisms
van Houte, S., Buckling, A., & Westra, E. R. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00011-16 · Cited by 245
Jaillard, M., Lima, L., Tournoud, M., Mahé, P., van Belkum, A., Lacroix, V., & Jacob, L. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007758 · Cited by 222
Self-citationThe hidden life of integrative and conjugative elements
Delavat, F., Miyazaki, R., Carraro, N., Pradervand, N., & van der Meer, J. R. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux008 · Cited by 215
“Incidentally, however, ICE may also contain CRISPR-Cas types themselves (van Belkum et al. 2015).”
BackgroundPseudomonas predators: understanding and exploiting phage–host interactions
De Smet, J., Hendrix, H., Blasdel, B. G., Danis-Wlodarczyk, K., & Lavigne, R. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.61 · Cited by 202
Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity
Borges, A. L., Zhang, J. Y., Rollins, M. F., Osuna, B. A., Wiedenheft, B., & Bondy-Denomy, J. (2018) · Cell · doi:10.1016/j.cell.2018.06.013 · Cited by 161
How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance
Gholizadeh, P., Köse, Ş., Dao, S., Ganbarov, K., Tanomand, A., Dal, T., Aghazadeh, M., Ghotaslou, R., Ahangarzadeh Rezaee, M., Yousefi, B., et al. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s247271 · Cited by 159
Distribution and molecular evolution of the anti-CRISPR family AcrIF7
Figueroa, W., Cazares, A., Cazares, D., Wu, Y., de la Cruz, A., Welch, M., Kameyama, L., Nobrega, F. L., & Guarneros, G. (2023) · PLOS Biology · doi:10.1371/journal.pbio.3002072 · Cited by 2
Metadata
- Authors
- van Belkum, A., Soriaga, L. B., LaFave, M. C., Akella, S., Veyrieras, J.-B., Barbu, E. M., Shortridge, D., Blanc, B., Hannum, G., Zambardi, G., Miller, K., Enright, M. C., Mugnier, N., Brami, D., Schicklin, S., Felderman, M., Schwartz, A. S., Richardson, T. H., Peterson, T. C., Hubby, B., & Cady, K. C.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2015-12-31
- Volume
- 6
- Issue
- 6
- Pages
- e01796-15
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2174616186
- Cited by
- 225
- References
- 67
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.